EMA Recommends Granting a Marketing Authorisation for Nirogacestat By Ogkologos - July 3, 2025 262 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with progressing desmoid tumours Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR Reunión anual de la American Society of Clinical Oncology de 2022:... June 6, 2022 Study Says Exercise Combats Side Effects of Chemo and Other Meds... July 7, 2021 New Treatment Helps Survivors Regain Sensation After Breast Cancer October 21, 2020 Five Questions With…Jim. April 28, 2022 Load more HOT NEWS FDA Grants Accelerated Approval to Infigratinib for Metastatic Cholangiocarcinoma Good-bye, Old Friend Cancer, COVID-19, and Competing Threats to Indigenous Health Navigating the Challenges of Gynecologic Cancer Survivorship: An Expert Perspective
